Mechanistic basis for PI3K inhibitor antitumor activity and adverse reactions in advanced breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-020-05618-1.pdf
Reference118 articles.
1. Mukohara T (2015) PI3K mutations in breast cancer: prognostic and therapeutic implications. Breast Cancer 7:111–123. https://doi.org/10.2147/BCTT.S60696
2. Mayer IA, Arteaga CL (2016) The PI3K/AKT pathway as a target for cancer treatment. Annu Rev Med 67:11–28. https://doi.org/10.1146/annurev-med-062913-051343
3. Keegan NM, Gleeson JP, Hennessy BT (2018) Morris PG PI3K inhibition to overcome endocrine resistance in breast cancer. Expert Opin Investig Drugs 27(1):1–15
4. Paddock MN, Field SJ, Cantley LC (2019) Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance. J Lipid Res 60(4):747–752. https://doi.org/10.1194/jlr.S092130
5. Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR, Bareja R, Ma Y, Harris EM, Sboner A, Beltran H, Rubin MA, Mukherjee S, Cantley LC (2018) Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560(7719):499–503. https://doi.org/10.1038/s41586-018-0343-4
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique;npj Breast Cancer;2024-01-31
2. Computational-guided approach for identification of PI3K alpha inhibitor in the treatment of hepatocellular carcinoma by virtual screening and water map analysis;Journal of Biomolecular Structure and Dynamics;2024-01-10
3. Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway;Journal of Translational Medicine;2024-01-03
4. Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B‐cell lymphomas;Cancer Science;2023-10-15
5. Therapeutic charisma of imidazo [2,1-b] [1,3,4]-thiadiazole analogues: a patent review;Pharmaceutical Patent Analyst;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3